Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NextPharma Completes Acquisition of Santen’s Tampere Manufacturing Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

NextPharma Completes Acquisition of Santen’s Tampere Manufacturing Facility

Bolsters position in the pharmaceutical industry in Finland

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Santen SA and NextPharma announced that the acquisition of Santen’s Tampere, Finland ophthalmic manufacturing facility including blow fill seal and operations by NextPharma, a European pharmaceutical contract development and manufacturing organization (CDMO), was completed on September 30, 2019. The acquisition was originally announced by Santen SA and NextPharma in January 2019.

The companies enter into a strategic partnership with NextPharma taking over the production of Santen’s products at the Tampere facility.

NextPharma has acquired the site fully staffed, with approximately 180 employees involved in manufacturing and its support functions, including quality control, quality assurance, IT and administration. As a result of the transfer, these employees are now employed by NextPharma Oy. A significant number of Santen Finland employees in sales and marketing, R&D, regulatory, quality assurance, pharmacovigilance, human resources, IT and administration functions are not affected by the acquisition and those roles continue being part of Santen.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics